Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
US Army
Moodys
Medtronic
Fish and Richardson

Generated: August 23, 2019

DrugPatentWatch Database Preview

Litigation Details for Medicines Company v. Hospira Inc. (D. Del. 2009)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Medicines Company v. Hospira Inc. (D. Del. 2009)

Docket   Try a Free Trial Date Filed 2009-10-08
Court District Court, D. Delaware Date Terminated 2014-04-15
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties APP PHARMACEUTICALS INC.; APP PHARMACEUTICALS LLC; BARR LABORATORIES INC.; BARR PHARMACEUTICALS LLC; GEORGE SVOKOS; HOSPIRA INC.; MEDICINES COMPANY; PLANTEX-USA, INC.; PLIVA D.D.; PLIVA-HRVATSKA D.O.O.; SPECIAL MASTER VINCENT J. POPPITI, -SM-; TEVA PARENTERAL MEDICINES INC.; TEVA PHARMACEUTICALS INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 5,196,404; 7,582,727; 7,598,343
Attorneys Aaron A. Barlow; Ali Ahmed; Angus Chen; Bradford P. Lyerla; Brian E. Farnan; Brian F. McMahon; Cecilia Ziniti; Christopher B. Essig; Christopher L. Robinson; David A. Zwally; Edgar H. Haug; Elena C. Norman; Emily A. Evans; Frederick L. Cottrell , III; George C. Lombardi; Gina Bassi; Gina M. Bassi; Ivan M. Poullaos; Jason James Rawnsley; John C. Phillips , Jr.; John M. Seaman; Julia M. Johnson; Katherine Nolan-Stevaux; Kristin E. Goran; Kyle W.K. Mooney; Laura D. Hatcher; Lynn M. Ulrich; Mark P. Walters; Mary Matterer; Maureen L. Rurka; Megan C. Haney; Monte Terrell Squire; Paul R. Findley; Porter F. Fleming; Richard K. Herrmann; Robert E. Colletti; Samantha L. Maxfield; Sara E. Gilloon; Sara Tonnies Horton; Sarah E. Delia; Tania Magoon; Trang Hoang; William F. Long
Firms Abrams & Bayliss LLP; Farnan LLP; Phillips, Goldman & Spence, P.A.; Phillips, Goldman, McLaughlin & Hall, P.A.; Richards, Layton & Finger, PA; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Medicines Company v. Hospira Inc.
The small molecule drug covered by the patents cited in this case is   Try a Free Trial .

Details for Medicines Company v. Hospira Inc. (D. Del. 2009)

Date Filed Document No. Description Snippet Link To Document
2014-03-31 827 Angiomax is also covered by U.S. Patent. No. 5,196, 404 ("the 404 patent"), which is listed in the… for infringement of U.S. Patent Nos. 7,582,727 ("the '727 patent") and 7,598,343 ("…quot;the '343 patent") (collectively, "the patents in suit"). The Medicines Company…and 17 ofthe '727 patent, as well as claims 1-3 and 7-11 ofthe '343 patent. Hospira contends that…and 17 ofthe '727 patent, as well as claims 1-3 and 7-11 ofthe '343 patent. Claim 1 of 1 Angiomax External link to document
2014-04-15 829 Judgment , i.e., claims 1-3, 7-10, and 17 of U.S. Patent No. 7,582,727727 patent") and claims 1-3 and 7-11 of U.S. Patent No. 7,598,343 ("the '343 patent"…each asserted claim of the '727 and '343 patents is entered in favor of The Medicines Company …the asserted claims of the '727 and '343 patents. Case 1:09-cv-00750-RGA Document 829 Filed 04/15…each asserted claim of the '727 and '343 patents External link to document
2014-04-15 830 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,582,727 B1; US 7,598,343 … 2009 21 May 2018 1:09-cv-00750 830 Patent None District Court, D. Delaware External link to document
2018-05-17 874 Motion to Dismiss asserted infringement of U.S. Patent Nos. 7,582,727 and 7,598,343 (“the patents-in- suit”). (D.I. 1, Case…MedCo”) filed suit against Hospira for alleged patent infringement arising out of Hospira’s filing of…declarations of non-infringement and invalidity of each patent-in-suit.1 (D.I. 6, Case No. 10-700- ER.) …Agreement covered the Angiomax created by the new, patented process. We leave this question for the district… Hospira’s Counterclaims for invalidity of the patents-in-suit. Grant of this motion would dispose of External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
Moodys
Johnson and Johnson
Cantor Fitzgerald
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.